Abstract
Previously, we showed that extracts of ripe seasonal sweet corn tassels possess anti-irritant and anti-oxidant activities. The chemical identification of corn tassel bioactives was investigated by HPLC analysis. The hydroalcoholic extracts are composed primarily ( > 85%) phenolic-type compounds. The predominant component from C18 columns were concentrated by reverse phase chromatography and purified to greater than 97-99% by preparative HPLC chromatography. The chemical was determined by mass and NMR spectrometry to be 4-hydroxy-1-oxindole-3-acetic acid (Tasselin A) with a M.W of 207 daltons. Purified Tasselin A inhibits melanin production in sporulating cultures of the common bread mold. An anti-tyrosinase enzyme assay showed that it inhibits mushroom tyrosinase enzyme (IC50 = 0.75mM), and has both antioxidant, and skin anti-irritant activities. There are no prior reports of bioactives derived from corn tassels with potential skin whitening activity, nor are any corn tassel bioactivities currently employed as ingredients in personal care or skin care products.
Keywords: Anti-tyrosinase, bioactives, corn tassels, 4-hydroxy-2-oxindole-3-acetic acid, melanin inhibitor, skin whitener, HPLC, kojic acid, tasselin A, anti-irritant
Current Bioactive Compounds
Title: Bioactives Derived from Ripe Corn Tassels: A Possible New Natural Skin Whitener, 4-Hydroxy-1-Oxindole-3-Acetic Acid
Volume: 7 Issue: 2
Author(s): John J. Wille and Mark A. Berhow
Affiliation:
Keywords: Anti-tyrosinase, bioactives, corn tassels, 4-hydroxy-2-oxindole-3-acetic acid, melanin inhibitor, skin whitener, HPLC, kojic acid, tasselin A, anti-irritant
Abstract: Previously, we showed that extracts of ripe seasonal sweet corn tassels possess anti-irritant and anti-oxidant activities. The chemical identification of corn tassel bioactives was investigated by HPLC analysis. The hydroalcoholic extracts are composed primarily ( > 85%) phenolic-type compounds. The predominant component from C18 columns were concentrated by reverse phase chromatography and purified to greater than 97-99% by preparative HPLC chromatography. The chemical was determined by mass and NMR spectrometry to be 4-hydroxy-1-oxindole-3-acetic acid (Tasselin A) with a M.W of 207 daltons. Purified Tasselin A inhibits melanin production in sporulating cultures of the common bread mold. An anti-tyrosinase enzyme assay showed that it inhibits mushroom tyrosinase enzyme (IC50 = 0.75mM), and has both antioxidant, and skin anti-irritant activities. There are no prior reports of bioactives derived from corn tassels with potential skin whitening activity, nor are any corn tassel bioactivities currently employed as ingredients in personal care or skin care products.
Export Options
About this article
Cite this article as:
J. Wille John and A. Berhow Mark, Bioactives Derived from Ripe Corn Tassels: A Possible New Natural Skin Whitener, 4-Hydroxy-1-Oxindole-3-Acetic Acid, Current Bioactive Compounds 2011; 7 (2) . https://dx.doi.org/10.2174/157340711796011115
DOI https://dx.doi.org/10.2174/157340711796011115 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review
Current Pharmaceutical Design Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Colorectal Cancer
Anti-Cancer Agents in Medicinal Chemistry Dietary Manipulation of Precursor Polyunsaturated Fatty Acids Modulates Eicosanoid and Endocannabinoid Synthesis: A Potential Tool to Control Tumor Development
Current Nutrition & Food Science Metabolic Activation of Herbal and Dietary Constituents and Its Clinical and Toxicological Implications: An Update
Current Drug Metabolism Role of Isoprenoid Compounds on Angiogenic Regulation: Opportunities and Challenges
Current Medicinal Chemistry Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts
Current Pharmaceutical Design Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in Cancer
Current Topics in Medicinal Chemistry Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
Current Pharmaceutical Biotechnology Novel Drugs for Chronic Lymphoid Leukemias: Mechanism of Action and Therapeutic Activity
Current Medicinal Chemistry Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis
Current Pharmaceutical Biotechnology Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication
Anti-Cancer Agents in Medicinal Chemistry Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Expression and Function of PPARs in Cancer Stem Cells
Current Stem Cell Research & Therapy In vivo Fluorescence Detection in Surgery: A Review of Principles, Methods, and Clinical Applications
Current Medical Imaging Characterization of MHC Ligands for Peptide Based Tumor Vaccination
Current Pharmaceutical Design TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta
Current Molecular Medicine Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
Current Cancer Therapy Reviews New Ketonethiosemicarbazones for Melanogenesis Inhibition
Current Bioactive Compounds Pharmacological Activation of Protein Phosphatase 2 A (PP2A): A Novel Strategy to Fight Against Human Malignancies?
Current Medicinal Chemistry